Michelson Medical Research Foundation’s State Street SPDR S&P China ETF GXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Hold
16,750
1.34% 21
2026
Q1
$1.56M Hold
16,750
1.58% 21
2025
Q4
$1.62M Hold
16,750
1.63% 19
2025
Q3
$1.76M Hold
16,750
1.53% 16
2025
Q2
$1.47M Hold
16,750
1.41% 18
2025
Q1
$1.44M Hold
16,750
1.21% 20
2024
Q4
$1.27M Hold
16,750
1.07% 25
2024
Q3
$1.38M Hold
16,750
0.97% 26
2024
Q2
$1.15M Hold
16,750
0.99% 24
2024
Q1
$1.1M Hold
16,750
0.67% 27
2023
Q4
$1.14M Buy
+16,750
New +$1.17M 0.75% 27

Other funds holding GXC

Michelson Medical Research Foundation's GXC Position: Q2 2026 in Review

Michelson Medical Research Foundation held its State Street SPDR S&P China ETF (GXC) position steady in Q2 2026 at 16,750 shares worth $1.45M. The position accounts for 1.34% of the portfolio, ranked #21.

Michelson Medical Research Foundation first reported a position in GXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.76M in Q3 2025. 74 funds tracked by Wall St. Rank hold GXC as of Q2 2026.

  • Michelson Medical Research Foundation held 16,750 shares of State Street SPDR S&P China ETF worth $1.45M as of Q2 2026.
  • Michelson Medical Research Foundation left its State Street SPDR S&P China ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P China ETF made up 1.34% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #21 holding.
  • Michelson Medical Research Foundation first reported a position in State Street SPDR S&P China ETF in Q4 2023 and has held it in 11 quarters since.
  • Michelson Medical Research Foundation's State Street SPDR S&P China ETF position peaked at $1.76M in Q3 2025.
  • 74 funds tracked by Wall St. Rank held State Street SPDR S&P China ETF as of Q2 2026.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.